Exercise + tDCS for Alzheimer's Disease
(EXACT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if combining exercise with brain stimulation can improve memory in individuals with memory problems due to Mild Cognitive Impairment or Alzheimer's disease. The brain stimulation, known as transcranial direct current stimulation (tDCS), uses a small electrical current to target active brain areas. Researchers will divide participants into groups to receive either both exercise and real tDCS, exercise and sham tDCS, or exercise advice and real tDCS. Individuals diagnosed with memory issues related to Alzheimer's who can read and communicate in English may be suitable for this trial. As an unphased trial, this study provides a unique opportunity to explore innovative treatments for memory improvement.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop all current medications, but you cannot join if you've changed cognitive enhancing medications in the last 3 months or anticonvulsants/psychotropic medications in the last month. You also cannot be taking benzodiazepines.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both exercise and transcranial direct current stimulation (tDCS) have been studied for their effects on brain health, both separately and together. For individuals with mild cognitive impairment or Alzheimer's disease, researchers have tested tDCS to determine if it can safely improve memory and brain function. A study on tDCS safety found it to be generally well-tolerated, with most participants experiencing only mild side effects like tingling or itching on the scalp where the device is placed.
Exercise is already known to be safe and beneficial for health, especially in older adults, and can help improve memory and slow cognitive decline. When combined with tDCS, it may enhance these positive effects. Overall, previous research considers the treatments in this trial safe. However, anyone interested in participating should consult their doctor about potential side effects and benefits.12345Why are researchers excited about this trial's treatments?
Researchers are excited about combining exercise with transcranial direct current stimulation (tDCS) for Alzheimer's disease because it offers a novel approach to managing the condition. Traditional treatments often involve medications like donepezil or memantine, which primarily target neurotransmitters. In contrast, tDCS is a non-invasive brain stimulation technique that may enhance cognitive function by modulating neural activity. Additionally, combining tDCS with personalized exercise programs could synergistically improve brain health and cognitive outcomes, offering a more holistic and potentially effective alternative to standard drug therapies.
What evidence suggests that this trial's treatments could be effective for Alzheimer's disease?
This trial will explore the effects of combining exercise with transcranial direct current stimulation (tDCS) on cognitive function in individuals with Alzheimer's disease. Research has shown that both exercise and tDCS can improve thinking and memory in people with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Exercise alone boosts overall brain health and specific thinking skills in older adults with MCI. Studies indicate that tDCS can significantly enhance general thinking abilities and focus. In this trial, some participants will receive both exercise and active tDCS, while others will receive exercise with sham tDCS or exercise education with active tDCS. Combining exercise and tDCS might be even more effective, particularly in improving thinking skills in those with dementia. Overall, this combination appears promising for helping people with MCI and AD improve their memory and thinking abilities.13467
Are You a Good Fit for This Trial?
This trial is for individuals over 50 with mild Alzheimer's or cognitive impairment who can communicate in English and have an MMSE score of at least 19. It's not suitable for those recently changing medication, using benzodiazepines, having metal implants like pacemakers, other significant neurological conditions, psychiatric disorders, substance use disorder, or medical reasons preventing exercise.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a combined exercise and tDCS intervention or control interventions over a 2-week period
Follow-up
Participants are monitored for changes in cognitive function and neuropsychiatric symptoms
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
- tDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor